| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/26/2000 | EP0470974B1 Lytic peptides, use for growth, infection and cancer |
| 01/25/2000 | US6018102 A recombinant dna molecule encoding a stabilized protein; where the dna is capable of replication but not expression in a prokaryotic cell and is capable of expression in eukaryotic cell; fungicides, viricides, bactericides, antiprotozoa agent |
| 01/25/2000 | US6018020 Amino acid derivatives |
| 01/25/2000 | US6018019 Immunogenic synthetic peptides which are useful alone or in conjugates in vaccines against hemophilus influenza infection |
| 01/25/2000 | US6017899 Non-reducing saccharide-forming enzyme, its preparation and uses |
| 01/25/2000 | US6017879 Template associated NPY Y2-receptor agonists |
| 01/25/2000 | US6017878 Nerve growth factor structural analogs and their uses |
| 01/25/2000 | US6017877 Method and composition for treating thrombosis |
| 01/25/2000 | US6017719 Targeting cells from heterogeneous suspension; forming cell complexes linked to antibody bound to surface antigen, separating complexes, mixing antibody with peptide that binds and displaces antibody from antigen, releasing target cell |
| 01/25/2000 | US6017509 Cyclic hexapeptides not comprised of a disulfide bond covalently linked to a radiolabel e.g. technetium; scintigraphic imaging agents; radiodiagnosis and -therapy; antitumor,-carcinogenic and -diabetic agents; stability |
| 01/20/2000 | WO2000003245A1 Peptide ligands for the human fibroblast growth factor (fgf) receptor |
| 01/20/2000 | WO2000002917A2 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | WO2000002916A2 PEPTIDE COMPOSITIONS MIMICKING TGF-β ACTIVITY |
| 01/20/2000 | WO2000002906A1 Dolastatin 15 derivatives |
| 01/20/2000 | WO2000002905A2 Methods for accelerating bone and cartilage growth and repair |
| 01/20/2000 | WO2000002904A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 01/20/2000 | WO2000002903A1 Cs-1 peptidomimetics, compositions and methods of using the same |
| 01/20/2000 | WO2000002898A1 Processes for coupling amino acids using bis-(trichloromethyl) carbonate |
| 01/20/2000 | CA2334076A1 Processes for coupling amino acids using bis-(trichloromethyl) carbonate |
| 01/20/2000 | CA2333928A1 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | CA2332641A1 Dolastatin 15 derivatives |
| 01/19/2000 | EP0972779A2 Oligonucleotide-polyamide conjugates |
| 01/19/2000 | EP0972564A2 Combinatorial strategies for polymer synthesis |
| 01/19/2000 | EP0972020A1 Insulin-like growth factor agonist peptides |
| 01/19/2000 | EP0971952A2 Diagnosis method and reagents |
| 01/19/2000 | EP0971948A2 Inhibitors for urokinase receptor |
| 01/19/2000 | EP0897392A4 Isolation and use of sh3 binding peptides |
| 01/18/2000 | US6015941 Peptide derivatives of tachyplesin having antimicrobial activity |
| 01/18/2000 | US6015904 Stable reagents for the preparation of radio pharmaceuticals |
| 01/18/2000 | US6015878 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application |
| 01/18/2000 | US6015794 Trans-splicing ribozymes |
| 01/18/2000 | US6015790 Methods and compositions for treating rheumatoid arthritis |
| 01/18/2000 | US6015787 Cell-permeable protein inhibitors of calpain |
| 01/18/2000 | US6015710 Specific nucleobase sequences; for administration to mammalian cells in vitro |
| 01/18/2000 | US6015701 N-acetylglucosaminyltransferase V proteins and coding sequences |
| 01/18/2000 | US6015695 Immunoglobulins devoid of light chains |
| 01/18/2000 | US6015561 Antigen binding peptides (abtides) from peptide libraries |
| 01/18/2000 | CA2005420C Competitive gonadoliberin antagonists |
| 01/13/2000 | WO2000001841A2 Hyaluronic acid mimics and methods related thereto |
| 01/13/2000 | WO2000001730A1 Peptides based on the sequence of human lactoferrin and their use |
| 01/13/2000 | WO2000001715A1 Novel cyclosporin with improved activity profile |
| 01/13/2000 | WO2000001706A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 01/13/2000 | WO2000001402A1 Antiproliferative and antiviral proteins and peptides |
| 01/13/2000 | WO1999043709A3 Melanocortin receptor antagonists and modulations of melanocortin receptor activity |
| 01/13/2000 | DE19920966A1 alpha-Ketoamidderivate alpha-Ketoamidderivate |
| 01/13/2000 | CA2346742A1 Hyaluronic acid mimics and methods related thereto |
| 01/13/2000 | CA2335918A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 01/12/2000 | EP0970965A1 Cyclic peptides and medicinal use thereof |
| 01/12/2000 | EP0970121A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
| 01/12/2000 | EP0970107A1 Cyclosporine derivatives and uses thereof |
| 01/12/2000 | EP0970106A1 uPAR MIMICKING PEPTIDE |
| 01/12/2000 | EP0548234B1 Cloning of chicken anaemia dna |
| 01/11/2000 | US6013781 Semaphorin gene family |
| 01/11/2000 | US6013770 Chimeric contraceptive vaccines |
| 01/11/2000 | US6013765 Cell surface peptides that can be used as antitumor agents |
| 01/11/2000 | US6013647 Benzoxazinedione derivatives, method of producing them and uses thereof |
| 01/11/2000 | US6013627 Organic compounds |
| 01/11/2000 | US6013625 Method and composition for treating thrombosis |
| 01/11/2000 | US6013481 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof |
| 01/11/2000 | US6013462 Purifying or analyzing a human glutathione-s-transferase from a sample by contacting with a solid support coupled to tripeptide analog, and allowing enzyme to adsorb to support |
| 01/11/2000 | US6013263 As inhibitory of human and non-human retroviral, especially human immunodeficiency viurs (hiv), transmission to uninfected cells |
| 01/11/2000 | US6013258 Immunogenic peptides from the HPV E7 protein |
| 01/06/2000 | WO2000000509A2 Peptides for inhibiting hpv e7 proteins |
| 01/06/2000 | WO2000000214A2 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 01/06/2000 | CA2332127A1 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 01/05/2000 | EP0969015A2 Peptide diagnostic markers for human disorders |
| 01/05/2000 | EP0969013A1 Peptides for inhibiting HPV E7 proteins |
| 01/05/2000 | EP0968230A1 Oxidized fragments of apolipoprotein b and their use |
| 01/05/2000 | EP0968186A1 Improved polyamides for binding in the minor groove of double stranded dna |
| 01/05/2000 | EP0967989A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 01/05/2000 | EP0758342B1 New peptide active substance and production thereof |
| 01/05/2000 | EP0579661B1 Branched peptides in assays for antibodies |
| 01/05/2000 | EP0570493B1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING |
| 01/05/2000 | CN1240357A Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 01/04/2000 | US6011137 Fusion proteins |
| 01/04/2000 | US6011136 Inhibitor of tumor necrosis factor; antiinflammatory agents |
| 01/04/2000 | US6011018 Regulated transcription of targeted genes and other biological events |
| 01/04/2000 | US6011010 Cytotoxic and antiviral compound |
| 01/04/2000 | US6010862 Methods of detecting collagen type III degradation in vivo |
| 01/04/2000 | US6010679 Transition metal radionucleolide; contrast agents for diagnosing cardiovascular disorders, cancer |
| 01/04/2000 | CA2045658C Polypeptides having a .beta.-adremergic receptor activity in humans, involved_in the lipolytic response, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of active substances on these polypeptides |
| 01/04/2000 | CA1340869C T cell activation markers |
| 12/29/1999 | WO1999067280A1 Novel method for preparing cyclosporin derivatives |
| 12/29/1999 | WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 12/29/1999 | WO1999066952A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/29/1999 | WO1999051626A3 Template associated npy y2-receptor agonists |
| 12/29/1999 | EP0967279A1 Helicobacter pylori cytotoxin useful for vaccines and diagnostics |
| 12/29/1999 | EP0967223A2 Hepatitis C virus peptide antigens and a method of testing for the hepatitis C virus (HCV) |
| 12/29/1999 | EP0967222A1 Cyclic depsipeptides and drugs containing the same as the active ingredient |
| 12/29/1999 | EP0966975A2 Diagnostic agents for pancreatic exocrine function |
| 12/29/1999 | EP0966545A2 Method for typing of minor histocompatibility antigen ha-1 |
| 12/29/1999 | EP0966481A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 12/29/1999 | EP0966480A2 Cysteine-depleted peptides recognized by a3-restricted cytotoxic lymphocytes, and uses therefor |
| 12/29/1999 | EP0966479A1 Polyprolyl inhibitors of cyclophilin |
| 12/29/1999 | EP0966297A1 Methods for regulating gastrointestinal motility |
| 12/29/1999 | EP0868716A4 Method for recovering data from disk with magneto-resistive head in presence of thermal asperities |
| 12/29/1999 | EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 12/29/1999 | CA2330249A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 12/29/1999 | CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors |